United States · FDA National Drug Code directory
Bosentan
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 47335-039_72ab60fc-63c5-4b1e-93ce-a21f3754e343
- Product NDC
- 47335-039
- Form
- TABLET, FILM COATED
- Composition / generic term
- Bosentan
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190426
- Source listing expiry
- 20261231
Source-listed ingredients
- BOSENTAN — 125 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 BLISTER PACK in 1 CARTON (47335-039-64) / 3 TABLET, FILM COATED in 1 BLISTER PACK (47335-039-60) · 47335-039-64
- 60 TABLET, FILM COATED in 1 BOTTLE (47335-039-86) · 47335-039-86
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →